PDCD1 and neoplasm: Although the majority of reports demonstrate an advantage of targeting the PD-1/PL1 axis in terms of increased anti-tumor properties8–17, it is worth noting that some studies have raised concerns about adverse effects associated with long-term PD-1 disruption, including induction of T cell exhaustion and impaired persistence18,19, implying certain discrepancies in the field.